Selected Papers from the 1st International Electronic Conference on Biomolecules
A special issue of Biomolecules (ISSN 2218-273X).
Deadline for manuscript submissions: closed (31 August 2021) | Viewed by 16893
Special Issue Editors
Interests: cancer systems biology; evolution; non-genetic mechanisms; intrinsically disordered proteins
Special Issues, Collections and Topics in MDPI journals
Interests: mycotoxins; fungal metabolites; antimicrobial; anticancer; antinflammatory; antioxidant
Special Issues, Collections and Topics in MDPI journals
Interests: protein physics; protein folding; protein misfolding; intrinsically disordered proteins; protein function; protein interactions
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The 1st International Electronic Conference on Biomolecules: Natural and Bio-Inspired Therapeutics for Human Diseases (IECBM2020) (https://sciforum.net/conference/IECBM2020) is organized by journal Biomolecules (Impact Factor 4.082) from 1 to 13 December 2020. This conference aims to provide leading scientists working in the field with an online platform on which to share their latest research and engage in exciting discussions. The main topics of the conference are:
- The natural and bio-inspired drug universe;
- Derivatives of natural drugs: when chemistry allows optimization of what was created by nature;
- Pathways for the discovery of new bio-inspired and natural drugs and their derivatives;
- Repurposing of previously approved natural and bio-inspired drugs.
This Special Issue is intended to collect the Extended and expanded versions of proceedings papers from the conference. All the conference participants will be granted a 20% discount on the Article Processing Charges (APC).
Prof. Dr. Prakash Kulkarni
Dr. Marc Maresca
Dr. Vladimir N. Uversky
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.